Avadel Pharmaceuticals PLC (AVDL)
15.95
+0.19
(+1.21%)
USD |
NASDAQ |
May 31, 16:00
15.95
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash from Investing (Quarterly): 21.39M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.39M |
| December 31, 2023 | 27.93M |
| September 30, 2023 | 9.821M |
| June 30, 2023 | -92.91M |
| March 31, 2023 | 5.066M |
| December 31, 2022 | 22.88M |
| September 30, 2022 | 2.524M |
| June 30, 2022 | 12.05M |
| March 31, 2022 | 42.25M |
| December 31, 2021 | 15.32M |
| September 30, 2021 | 12.29M |
| June 30, 2021 | 18.12M |
| March 31, 2021 | 11.19M |
| December 31, 2020 | 7.241M |
| September 30, 2020 | -9.30M |
| June 30, 2020 | -80.89M |
| March 31, 2020 | 13.23M |
| December 31, 2019 | 5.17M |
| September 30, 2019 | 3.217M |
| June 30, 2019 | 8.946M |
| March 31, 2019 | 21.39M |
| December 31, 2018 | 16.21M |
| September 30, 2018 | 26.02M |
| June 30, 2018 | 1.527M |
| March 31, 2018 | -80.74M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.531M |
| September 30, 2017 | 1.077M |
| June 30, 2017 | 15.74M |
| March 31, 2017 | -31.99M |
| December 31, 2016 | 13.46M |
| September 30, 2016 | 0.026M |
| June 30, 2016 | -9.127M |
| March 31, 2016 | -40.99M |
| December 31, 2015 | -8.602M |
| September 30, 2015 | -12.57M |
| June 30, 2015 | 12.87M |
| March 31, 2015 | -23.43M |
| December 31, 2014 | 13.98M |
| September 30, 2014 | -32.93M |
| June 30, 2014 | 3.661M |
| March 31, 2014 | -27.79M |
| December 31, 2013 | 1.827M |
| September 30, 2013 | -0.292M |
| June 30, 2013 | -0.087M |
| March 31, 2013 | 4.597M |
| December 31, 2012 | 5.964M |
| September 30, 2012 | 3.214M |
| June 30, 2012 | 1.629M |
| March 31, 2012 | 4.641M |
| December 31, 2011 | 0.462M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-92.91M
Minimum
Jun 2023
42.25M
Maximum
Mar 2022
2.777M
Average
10.51M
Median
Cash from Investing (Quarterly) Benchmarks
| Trinity Biotech PLC | -13.96M |
| Amarin Corp PLC | 28.72M |
| Medtronic PLC | -696.00M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.70M |
| Cash from Financing (Quarterly) | 13.19M |
| Free Cash Flow | -127.98M |
| Free Cash Flow Per Share (Quarterly) | -0.324 |
| Free Cash Flow to Equity (Quarterly) | -29.70M |
| Free Cash Flow to Firm (Quarterly) | -27.10M |
| Free Cash Flow Yield | -9.22% |